Volume 40 Issue 5
Sep.  2019
Turn off MathJax
Article Contents
Zhen-Zhen Chen, Yu-Yu Niu. Stem cell therapy for Parkinson’s disease using non-human primate models. Zoological Research, 2019, 40(5): 349-357. doi: 10.24272/j.issn.2095-8137.2019.053
Citation: Zhen-Zhen Chen, Yu-Yu Niu. Stem cell therapy for Parkinson’s disease using non-human primate models. Zoological Research, 2019, 40(5): 349-357. doi: 10.24272/j.issn.2095-8137.2019.053

Stem cell therapy for Parkinson’s disease using non-human primate models

doi: 10.24272/j.issn.2095-8137.2019.053
Funds:  the National Key R&D Program of China(2016YFA0101401)
More Information
  • Corresponding author: Yu-Yu Niu
  • Received Date: 2019-03-19
  • Publish Date: 2019-09-18
  • Stem cell therapy (SCT) for Parkinson’s disease (PD) has received considerable attention in recent years. Non-human primate (NHP) models of PD have played an instrumental role in the safety and efficacy of emerging PD therapies and facilitated the translation of initiatives for human patients. NHP models of PD include primates with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism, who are responsive to dopamine replacement therapies, similar to human PD patients. Extensive research in SCT has been conducted to better treat the progressive dopaminergic neurodegeneration that underlies PD. For effective application of SCT in PD, however, a number of basic parameters still need to be tested and optimized in NHP models, including preparation and storage of cells for engraftment, methods of transplantation, choice of target sites, and timelines for recovery. In this review, we discuss the current status of NHP models of PD in stem cell research. We also analyze the advances and remaining challenges for successful clinical translation of SCT for this persistent disease.
  • loading
  • [1]
    null Abe S , Yamaguchi S , Sato Y , Harada K . 2016. Sphere-derived multipotent progenitor cells obtained from human oral mucosa are enriched in neural crest cells. Stem Cells Translational Medicine, 5(1): 117–128.
    null Ai Z , Xiang Z , Li Y , Liu G , Wang H , Zheng Y , Qiu X , Zhao S , Zhu X , Li Y , Ji W , Li T . 2016. Conversion of monkey fibroblasts to transplantable telencephalic neuroepithelial stem cells. Biomaterials, 77: 53–65.
    null Bacigaluppi M , Russo GL , Peruzzotti-Jametti L , Rossi S , Sandrone S , Butti E , De Ceglia R , Bergamaschi A , Motta C , Gallizioli M , Studer V , Colombo E , Farina C , Comi G , Politi LS , Muzio L , Villani C , Invernizzi RW , Hermann DM , Centonze D , Martino G . 2016. Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes. The Journal of Neuroscience, 36(41): 10529–10544.
    null Barker RA , Parmar M , Studer L , Takahashi J . 2017. Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era. Cell Stem Cell, 21(5): 569–573.
    null Bentlage C , Nikkhah G , Cunningham MG , Bjorklund A . 1999. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Experimental Neurology, 159(1): 177–190.
    null Bergstrom R , Strom S , Holm F , Feki A , Hovatta O . 2011. Xeno-free culture of human pluripotent stem cells. Methods in Molecular Biology, 767: 125–136.
    null Bernstein AI, Garrison SP , Zambetti GP , O'malley KL . 2011. 6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death. Molecular Neurodegenerati., 6(1): 2–10.
    null Bjugstad KB , Redmond DE, Teng YD , Elsworth JD , Roth RH , Blanchard BC , Snyder EY , Sladek JR . 2005. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: A return to control measures. Cell Transplantation, 14(4): 183–192.
    null Bjugstad KB , Teng YD , Redmond DE, Jr., Elsworth JD , Roth RH , Cornelius SK , Snyder EY , Sladek JR , Jr . 2008. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Experimental Neurology, 211(2): 362–369.
    null Bove J , Perier C . 2012. Neurotoxin-based models of Parkinson's disease. Neuroscience, 211: 51–76.
    null Camus S , Ko WKD , Pioli E , Bezard E . 2015. Why bother using non-human primate models of cognitive disorders in translational research?. Neurobiology of Learning and Memory, 124: 123–129.
    null Chiu AY , Hall ZW . 2006. Stem cell research: the California experience. The Journal of Neuroscience, 26(25): 6661–6663.
    null Choi DH , Kim JH , Kim SM , Kang K , Han DW , Lee J . 2017. Therapeutic potential of induced neural stem cells for Parkinson's disease. International Journal of Molecular Sciences, 18(1): E224.
    null Cicchetti F , Drouin-Ouellet J , Gross RE . 2010. Viability of the rotenone model in question. Trends in Pharmacological Sciences, 31(4): 142–143.
    null Cimdins K , Waugh HS , Chrysostomou V , Lopez Sanchez MIG , Johannsen VA , Cook MJ , Crowston JG , Hill AF , Duce JA , Bush AI, Trounce IA . 2019. Amyloid precursor protein mediates neuronal protection from rotenone toxicity. Molecular Neurobiology, 2(3): 55–62.
    null Cowen D . 1986. The melanoneurons of the human cerebellum (nucleus pigmentosus cerebellaris) and homologues in the monkey. Journal of Neuropathology and Experimental Neurology, 45(3): 205–221.
    null Coizet V , Heilbronner SR , Carcenac C , Mailly P , Lehman JF , Savasta M , David O , Deniau JM , Groenewegen HJ , Haber SN . 2017. Organization of the anterior limb of the internal capsule in the rat. The Journal of Neuroscience, 37(10): 2539–2554.
    null Collier TJ , Redmond DE, Steece-Collier K , Lipton JW , Manfredsson FP . 2016. Is alpha-synuclein loss-of-function a contributor to Parkinsonian pathology? Evidence from Non-human Primates. Frontiers in Neuroscience, 10(5): 12–20.
    null Cyranoski D . 2017. Trials of embryonic stem cells to launch in China. Nature, 546(7656): 15–16.
    null Dauer W , Przedborski S . 2003. Parkinson's disease: Mechanisms and models. Neuron, 39(6): 889–909.
    null Didier ES , Maclean AG , Mohan M , Didier PJ , Lackner AA , Kuroda MJ . 2016. Contributions of nonhuman primates to research on aging. Veterinary Pathology, 53(2): 277–290.
    null Emborg ME . 2004. Evaluation of animal models of Parkinson's disease for neuroprotective strategies. Journal of Neuroscience Methods, 139(2): 121–143.
    null Drouin-Ouellet J . 2014. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease. Neurodegenerative disease management, 4(4): 297–307.
    null Howson PA , Johnston TH , Ravenscroft P , Hill MP , Su J , Brotchie JM , Koprich JB . 2019. Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics, 369(3): 364–374.
    null Emborg ME . 2017. Nonhuman primate models of neurodegenerative disorders. Ilar Journal, 58(2): 190–201.
    null Eslamboli A , Baker HF , Ridley RM , Annett LE . 2003. Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys. Experimental Neurology, 183(2): 418–429.
    null Eslamboli A , Georgievska B , Ridley RM , Baker HF , Muzyczka N , Burger C , Mandel RJ , Annett L , Kirik D . 2005. Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. The Journal of Neuroscience, 25(4): 769–777.
    null Eslamboli A , Romero-Ramos M , Burger C , Bjorklund T , Muzyczka N , Mandel RJ , Baker H , Ridley RM , Kirik D . 2007. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain, 130: 799–815.
    null Fallahi-Sichani M , Soleimani M , Najafi SMA , Kiani J , Arefian E , Atashi A . 2007. In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. Cell Biology International, 31(3): 299–303.
    null Hallett PJ , Deleidi M , Astradsson A , Smith GA , Cooper O , Osborn TM , Sundberg M , Moore MA , Perez-Torres E , Brownell AL , Schumacher JM , Spealman RD , Isacson O . 2015. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease. Cell Stem Cell, 16(3): 269–274.
    null Han F , Wang W , Chen B , Chen C , Li S , Lu X , Duan J , Zhang Y , Zhang YA , Guo W , Li G . 2015. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease. Cytotherapy, 17(5): 665–679.
    null Handschel J , Naujoks C , Depprich R , Lammers L , Kübler N , Meyer U , Wiesmann H . 2011. Embryonic stem cells in scaffold-free three-dimensional cell culture: osteogenic differentiation and bone generation. Head & Face Medicine, 7(1): 12–12.
    null Hayashi T , Wakao S , Kitada M , Ose T , Watabe H , Kuroda Y , Mitsunaga K , Matsuse D , Shigemoto T , Ito A , Ikeda H , Fukuyama H , Onoe H , Tabata Y , Dezawa M . 2013. Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques. Journal of Clinical Investigation, 123(1): 272–284.
    null Huang B , Wu S , Wang Z , Ge L , Rizak J , Wu J , Li J , Xu L , Lv L , Yin Y , Hu X , Li H . 2018. Phosphorylated α-synuclein accumulations and lewy body-like pathology distributed in Parkinson's disease-related brain areas of aged rhesus monkeys treated with MPTP. Neuroscience, 379: 302–315.
    null Johnson ME , Stringer A , Bobrovskaya L . 2018. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease. Neurotoxicology, 65: 174–185.
    null Jiang PZ , Dickson DW . 2018. Parkinson's disease: experimental models and reality. Acta Neuropathologica, 135(1): 13–32.
    null Kauhausen JA , Thompson LH , Parish CL . 2015. Chondroitinase improves midbrain pathway reconstruction by transplanted dopamine progenitors in parkinsonian mice. Molecular & Cellular Neuroscience, 69: 22–29.
    null Kern DS , Maclean KN , Jiang H , Synder EY , Sladek JR , Jr., Bjugstad KB . 2011. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn down syndrome mice. Cell Transplantation, 20(3): 371–379.
    null Kern R , Garitaonandia I , Gonzalez R , Sherman G , Noskov A , Cardiff D , Christiansen-Weber T , Semechkin A , Braine E , Shahrul A , Nair G , Evans A . 2018. Interim clinical assessment of a neural stem cell Based therapy for Parkinson's disease. Neurology, 90(1): 12–12.
    null Kikuchi T , Morizane A , Doi D , Magotani H , Onoe H , Hayashi T , Mizuma H , Takara S , Takahashi R , Inoue H , Morita S , Yamamoto M , Okita K , Nakagawa M , Parmar M , Takahashi J . 2017. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature, 548(7669): 592–596.
    null Kim SH , Hong JY , Joo SY , Kim JH , Moon SY , Yoon HS , Kim DH , Chung HM , Choi SJ . 2004. Derivation of neural precursor cells from human embryonic stem cells. Reproductive & Developmental Biology, 28(4): 247–252.
    null Kim SU , Lee HJ , Kim YB . 2013. Neural stem cell-based treatment for neurodegenerative diseases. Neuropathology, 33(5): 491–504.
    null Kim JH , Auerbach JM , Rodriguez-Gomez JA , Velasco I , Gavin D , Lumelsky N , Lee SH , Nguyen J , Sanchez-Pernaute R , Bankiewicz K , Mckay R . 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature, 418(6893): 50–56.
    null Kirik D , Annett L , Burger C , Muzyczka N , Mandel RJ , Bj?rklund A . 2003. Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein: a new primate model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America, 100(5): 2884–2889.
    null Koprich JB , Johnston TH , Reyes G , Omana V , Brotchie JM . 2016. Towards a non-human primate model of alpha-synucleinopathy for development of therapeutics for Parkinson's disease: optimization of AAV1/2 delivery parameters to drive sustained expression of alpha synuclein and dopaminergic degeneration in Macaque. PLoS One, 11(11): e0167235.
    null Koprich JB , Johnston TH , Su J , Fox SH , Ma YL , Zuo CT , Guan YH , Brotchie JM . 2017. A non-human primate model of Parkinson's disease based on viral vector mediated overexpression of alpha-synuclein. Acta Pharmacologica Sinica, 38(7): 1090–1090.
    null Kostrzewa RM . 2000. Review on apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease. Neurotoxicity Research, 2(2–3): 239–250.
    null Kuo TL & Yu HY . 1991. Effect of ethanol on the disposition of paraquat. Toxicology Letters, 58(1): 107–115.
    null Kuter K , Nowak P , Golembiowska K , Ossowska K . 2010. Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues. Neurochemical Research, 35(8): 1121–1130.
    null Kuter K , Smia?owska M , Wieronska J , Zieba B , Wardas J , Pietraszek M , Nowak P , Biedka I , Roczniak W , Konieczny J , Wolfarth S , Ossowska K . 2007. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Research, 1155: 196–207.
    null Kwak KA , Lee SP , Yang JY , Park YS . 2018. Current perspectives regarding stem cell-based therapy for Alzheimer's disease. Stem Cells International, 2018: 1–14.
    null L'episcopo F , Tirolo C , Peruzzotti-Jametti L , Serapide MF , Testa N , Caniglia S , Balzarotti B , Pluchino S , Marchetti B . 2018. Neural stem cell grafts promote astroglia-driven neurorestoration in the aged Parkinsonian brain via wnt/beta-catenin signaling. Stem Cells, 36(8): 1179–1197.
    null Leng LG , Tian ZM . 2016. Transplantation of neural precursor cells in the treatment of Parkinson disease: an efficacy and safety analysis. Turkish Neurosurgery, 26(3): 378–383.
    null Perier C , Bove J , Vila M , Przedborski S . 2003. The rotenone model of Parkinson's disease. Trends in Neurosciences, 26(7): 345–346.
    null Lei X , Li H , Huang B , Rizak J , Li L , Xu L , Liu L , Wu J , Lü L , Wang Z , Hu YZ , Le WD , Deng XL , Li JL , Yao YG , Xu L , Hu XT , Zhang BR . 2016. 1-methyl-4-phenylpyridinium stereotactic infusion completely and specifically ablated the nigrostriatal dopaminergic pathway in rhesus macaque. PLoS One, 11(1): e0147094.
    null Li H , Ding C , Ding Z , Ling M , Wang T , Wang W , Huang B . 2017. 17β-Oestradiol promotes differentiation of human embryonic stem cells into dopamine neurons via cross-talk between insulin-like growth factors-1 and oestrogen receptor β. Journal of Cellular and Molecular Medicine, 21(8): 1605–1618.
    null Li H , Lei XG , Huang BH , Rizak JD , Yang LC , Yang SC , Wu J , Lu LB , Wang JH , Yan T , Li HW , Wang ZB , Hu YZ , Le WD , Deng XL , Huang TZ , Li JL , Xu L , Zhang BR , Hu XT . 2015a. A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections. Journal of Neuroscience Methods, 251: 99–107.
    null Li W , Chen SD , Li JY . 2015b. Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling. Progress in Neurobiology, 134(5): 161–177.
    null Lu HF , Chai C , Lim TC , Leong MF , Lim JK , Gao S , Lim KL , Wan ACA . 2014. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells. Biomaterials, 35(9): 2816–2826.
    null Luk KC , Kehm V , Carroll J , Zhang B , O'brien P , Trojanowski JQ , Lee VMY . 2012. Pathological α-synuclein transmission initiates parkinson-like neurodegeneration in nontransgenic mice. Science, 338(6109): 949–953.
    null Luo X , Li M , Su B . 2016. Application of the genome editing tool CRISPR/Cas9 in non-human primates. Zoological Research, 37(4): 214–219.
    null Malloy KE, Li J , Choudhury GR , Torres A , Gupta S , Kantorak C , Goble T , Fox PT , Clarke GD , Daadi MM . 2017. Magnetic resonance imaging-guided delivery of neural stem cells into the basal ganglia of nonhuman primates reveals a pulsatile mode of cell dispersion. Stem Cells Translational Medicine, 6(3): 877–885.
    null Marmion D , Kordower J . 2018. α-Synuclein nonhuman primate models of Parkinson's disease. Journal of Neural Transmission, 125(3): 385–400.
    null Morizane A , Kikuchi T , Hayashi T , Mizuma H , Takara S , Doi H , Mawatari A , Glasser MF , Shiina T , Ishigaki H , Itoh Y , Okita K , Yamasaki E , Doi D , Onoe H , Ogasawara K , Yamanaka S , Takahashi J . 2017. MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nature Communications, 8(1): 385–385.
    null Niu Y , Guo X , Chen Y , Wang C , Gao J , Yang W , Kang Y , Si W , Wang H , Yang S , Li S , Ji W , Li X . 2015. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys. Human Molecular Genetics, 24(8): 2308–2317.
    null Pardal R , Barneo JL . 2012. Neural stem cells and transplantation studies in Parkinson's disease. Advances in Experimental Medicine and Biology, 741(1): 206–216.
    null Park JB , Lee JS , Cho BP , K-J Rhee , Baik SK , Kim J , Kang SJ , D-J Park , J-E Oh , Shin HC , Kim YM , Kim HS , Bae KS , Eom YW . 2015. Adipose tissue-derived mesenchymal stem cells cultured at high cell density express brain-derived neurotrophic factor and exert neuroprotective effects in a 6-hydroxydopamine rat model of Parkinson's disease. Genes & Genomics, 37(2): 213–221.
    null Parmar M . 2018. Towards stem cell based therapies for Parkinson's disease. Development, 145(1): 201–204.
    null Paumier K , Luk K , Manfredsson F , Kanaan N , Lipton J , Collier T , Collier KS , Kemp C , Celano S , Schulz E , Sandoval I , Fleming S , Dirr E , Polinski N , Trojanowski J , Lee V , Sortwell C . 2015. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiology of Disease, 82(3): 185–199.
    null Recasens A , Dehay B , Bove J , Carballo-Carbajal I , Dovero S , Perez-Villalba A , P-O Fernagut , Blesa J , Parent A , Perier C , Farinas I , Obeso JA , Bezard E , Vila M . 2014. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Annals of Neurology, 75(3): 351–362.
    null Robinson R . 2018. At the bench-amyotrophic lateral sclerosis: in the lab, regulatory T cells slow ALS. Neurology Today, 18(2): 225–231.
    null Sanders LH , Greenamyre JT . 2013. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radical Biology and Medicine, 62(3): 111–120.
    null Santana M , Palmér T , Simplício H , Fuentes R , Petersson P . 2015. Characterization of long-term motor deficits in the 6-OHDA model of Parkinson's disease in the common marmoset. Behavioural Brain Research, 290(9): 90–101.
    null Sarwar N , Ishaq W , Farid G , Shaheen MR , Imran M , Geng M , Hussain S . 2015. Zinc-cadmium interactions: Impact on wheat physiology and mineral acquisition. Ecotoxicology and Environmental Safety, 122(1): 528–536.
    null Shirani A , Stuve O . 2018. Natalizumab: Perspectives from the bench to bedside. Cold Spring Harbor Perspectives in Medicine, 8(12): a029066.
    null Silvestrini MT , Yin D , Martin AJ , Coppes VG , Mann P , Larson PS , Starr PA , Zeng X , Gupta N , Panter SS , Desai TA , Lim DA . 2015. Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deployment. Molecular Therapy, 23(1): 119–129.
    null Skerjanc IS & Wilton S . 2000. Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells. FEBS Letters, 472(1): 53–56.
    null Smirnova L , Harris G , Delp J , Valadares M , Pamies D , Hogberg HT , Waldmann T , Leist M , Hartung T . 2016. A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis. Archives of Toxicology, 90(11): 2725–2743.
    null Sonntag KC , Song B , Lee N , Jung JH , Cha Y , Leblanc P , Neff C , Kong SW , Carter BS , Schweitzer J , Kim K-S . 2018. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Progress in Neurobiology, 168(2): 1–20.
    null Su LY , Li H , Lv L , Feng YM , Li GD , Luo RC , Zhou HJ , Lei XG , Ma L , Li JL , Xu L , Hu XT , Yao YG . 2015. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation. Autophagy, 11(10): 1745–1759.
    null Thomson JA , Itskovitz-Eldor J , Shapiro SS , Waknitz MA , Swiergiel JJ , Marshall VS , Jones JM . 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282(5391): 1145–1147.
    null Thompson LH , Shane G , Deniz K , Anders BR . 2010. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. European Journal of Neuroscience, 30(4): 625–638.
    null Tobón-Velasco JC , Limón-Pacheco JH , Orozco-Ibarra M , Macías-Silva M , Vázquez-Victorio G , Cuevas E , Ali SF , Cuadrado A , Pedraza-Chaverrí J , Santamaría A . 2013. 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors. Toxicology, 304(3): 109–119.
    null Trigo DI, del Rey NL , Blesa J . 2018. Novel models for Parkinson's disease and their impact on future drug discovery. Expert Opinion on Drug Discovery, 13(3): 229–239.
    null Vaccari C , El Dib R , De Camargo JLV . 2017. Paraquat and Parkinson's disease: a systematic review protocol according to the OHAT approach for hazard identification. Systematic Reviews, 6(1): 98–98.
    null Vermilyea SC , Emborg ME . 2018. The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease. Journal of Neural Transmission, 125(3): 365–384.
    null Vierboom M , Breedveld E , Hart BA T . 2012. New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis. Expert Opinion on Drug Discovery, 7(4): 315–325.
    null Wang HW , Lin LM , He HY , You F , Li WZ , Huang TH , Ma GX , Ma L . 2011. Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. Chinese Medical Journal, 124(10): 1534–1539.
    null Wang S , Okun MS , Suslov O , Zheng T , Mcfarland NR , Vedam-Mai V , Foote KD , Roper SN , Yachnis AT , Siebzehnrubl FA , Steindlera DA . 2012. Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains. Brain Research, 1464(1): 61–72.
    null Wang ZB , Qin DD , Hu XT . 2017. Engrafted newborn neurons could functionally integrate into the host neuronal network. Zoological Research, 38(1): 5–6.
    null Wei JK , Wang WC , Zhai RW , Zhang YH , Yang SC , Rizak J , Li L , Xu LQ , Liu L , Pan MK , Hu YZ , Ghanemi A , Wu J , Yang LC , Li H , Lv LB , Li JL , Yao YG , Xu L , Feng XL , Yin Y , Qin DD , Xu XT , Wang ZB . 2016. Neurons differentiated from transplanted stem cells respond functionally to acoustic stimuli in the awake monkey brain. Cell Reports, 16(4): 1016–1025.
    null Weick JP , Liu Y , Zhang SC . 2011. Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network. Proceedings of the National Academy of Sciences of the United States of America, 108(50): 20189–20194.
    null Xu J , Wang D , Liu D , Fan Z , Zhang H , Liu O , Ding G , Gao R , Zhang C , Ding Y , Bromberg JS , Chen W , Sun L , Wang S . 2012. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood, 120(15): 3142–3151.
    null Yang WL , Wang GH , Wang CE , Guo XY , Yin P , Gao JQ , Tu ZC , Wang ZB , Wu J , Hu XT , Li SH , Li XJ . 2015. Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain. The Journal of Neuroscience, 35(21): 8345–8358.
    null Zhang X , Hu D , Shang Y , Qi X . 2019. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Biochimica et Biophysica Acta, 5(1): 67–75.
    null Zhang XL , Pang W , Hu XT , Li JL , Yao YG , Zheng YT . 2014. Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress. Zoological Research, 35(6): 447–464.
    null Zhao B , Zhang WD , Duan YL , Lu YQ , Cun YX , Li CH , Guo K , Nie WH , Li L , Zhang R , Zheng P . 2015. Filia is an ESC-specific regulator of DNA damage response and safeguards genomic stability. Cell Stem Cell, 16(6): 684–698.
    null Zhou L , Cheng Y . 2019. Alpha-lipoic acid alleviated 6-OHDA-induced cell damage by inhibiting AMPK/mTOR mediated autophagy. Neuropharmacology, 155: 98–103.
    null Zhou Q , Zhang H , Wu Q , Shi J , Zhou S . 2017. Pharmacological manipulations of autophagy modulate paraquat-induced cytotoxicity in PC12 cells. International Journal of Biochemistry and Molecular Biology, 8(2): 13–22.
  • Relative Articles

    [1] Xue-Hui Wang, Tian-Zhang Song, Lei Li, Ren-Rong Tian, Yong-Tang Zheng. Successful implementation of intestinal resection and anastomosis in non-human primates suggests the possibility of longitudinal intestinal research. Zoological Research, 2020, 41(4): 449-454.  doi: 10.24272/j.issn.2095-8137.2020.049
    [2] Dong-Dong Qin, Shu-Fei Feng, Fei-Yu Zhang, Na Wang, Wen-Jie Sun, Yin Zhou, Teng-Fang Xiong, Xian-Lai Xu, Xiao-Ting Yang, Xiang Zhang, Xue Zhu, Xin-Tian Hu, Lei Xiong, Yun Liu, Yong-Chang Chen. Potential use of actigraphy to measure sleep in monkeys: comparison with behavioral analysis from videography. Zoological Research, 2020, 41(4): 437-443.  doi: 10.24272/j.issn.2095-8137.2020.056
    [3] Bo Zhang, Zhi-Gang Zhou, Yin Zhou, Yong-Chang Chen. Increased attention to snake images in cynomolgus monkeys: an eye-tracking study. Zoological Research, 2020, 41(1): 32-38.  doi: 10.24272/j.issn.2095-8137.2020.005
    [4] Bo Zhang. Consequences of early adverse rearing experience(EARE) on development: insights from non-human primate studies. Zoological Research, 2017, 38(1): 7-35.  doi: 10.13918/j.issn.2095-8137.2017.002
    [5] Jia-Li LI, Yong-Tang ZHENG, Xu-Dong ZHAO, Xin-Tian HU. Meeting report: the 4th symposium on animal models of non-human primates in Kunming, Yunnan, China. Zoological Research, 2016, 37(6): 361-365.  doi: 10.13918/j.issn.2095-8137.2016.6.361
    [6] Xin LUO, Min LI, Bing SU. Application of the genome editing tool CRISPR/Cas9 in non-human primates. Zoological Research, 2016, 37(4): 214-219.  doi: 10.13918/j.issn.2095-8137.2016.4.214
    [7] Jian-Hong WANG. Non-human primate models in drug addiction deserve more attention. Zoological Research, 2014, 35(3): 172-173.  doi: 10.11813/j.issn.0254-5853.2014.3.172
    [8] Xiao-Liang ZHANG, Wei PANG, Xin-Tian HU, Jia-Li LI, Yong-Gang YAO, Yong-Tang ZHENG. Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress. Zoological Research, 2014, 35(6): 447-464.  doi: 10.13918/j.issn.2095-8137.2014.6.447
    [9] Peng-Lai FAN, Zuo-Fu XIANG. Ecotourism disturbances to non-human primates. Zoological Research, 2013, 34(1): 55-58.  doi: 10.3724/SP.J.1141.2013.01055
    [10] . Special Issue for Primates and Animal Models of Human Diseases. Zoological Research, 2012, 33(1): 1-118.
    [11] GUO Li-Yun, WEI Jing-Kuan, YANG Shang-Chuan, WANG Zheng-Bo. Glaucoma model for stem cell transplantation research in New Zealand white rabbits. Zoological Research, 2012, (2): 225-230.  doi: 10.3724/SP.J.1141.2012.02225
    [12] WU Xu-Jun, ZONG Wei, SUN Yong-Mei, HU Xin-Tian, MA Yuan-Ye, WANG Jian-Hong. Morphine addiction in non-human primates using rhesus monkeys. Zoological Research, 2012, 33(1): 89-91.  doi: 10.3724/SP.J.1141.2012.01089
    [13] ZHANG Jing, QI Xiao-Guang, ZHANG Kan, ZHANG Pei, GUO Song-Tao, WEI Wei, LI Bao-Guo. Diversity and development of positional behavior in non-human primates. Zoological Research, 2012, 33(5): 511-522.  doi: 10.3724/SP.J.1141.2012.05511
    [14] XIA Hou-Jun, CHEN Ce-Shi. Progress of non-human primate animal models of cancers. Zoological Research, 2011, 32(1): 70-80.  doi: 10.3724/SP.J.1141.2011.01070
    [15] CHEN Yan-Mei, QIN Dong-Dong, JIANG Hui-Hui, HU Xin-Tian, MA Yuan-Ye. Sleep disorder, a potential early diagnostic marker for psychiatric and neurodegenerative diseases. Zoological Research, 2011, 32(1): 81-90.  doi: 10.3724/SP.J.1141.2011.01081
    [16] XIANG Ying, CHEN Song, LI Jun-hua, ZHONG Shan, WANG Wan-yu, XIONG Yu-lang, Chen. Immunogenicity of Yunnan-cobra Venom Factor in Non-human Primates. Zoological Research, 2008, 29(5): 511-517.  doi: 10.3724/SP.J.1141.200805511
    [17] LI Bin, CHEN Hong-wei, HU Zhi-xing, TAN Tao, JIN Li-fang, WANG Shu-fen, JI Wei-zhi, *. Differentiation of Human Embryonic Stem Cells to Neural Progenitors. Zoological Research, 2007, 28(3): 311-319.
    [18] ZHANG Peng*, WATANABE Kunio. On the Husbandry and Welfare of Captive Non-human Primates. Zoological Research, 2007, 28(4): 448-456.
    [19] JI Wei-zhi, ZOU Ru-jin, SHANG En-yuan, MEN Hong-sheng, YANG Shang-chuan. Application and Conservation of Non-Human Primates in Biomedical Research. Zoological Research, 1996, 17(4): 509-519.
    [20] JI Wei-zhi, YANG Shang-chuan, CHEN Jian-chung, ZOU Ru-jin, SHAN En-yuan. In Vitro Fertilization and Embryo Transfer in Non-Human Primates. Zoological Research, 1993, 14(3): 283-292.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1021) PDF downloads(454) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return